|
YME1L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.45839999999787E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.233500E-04 |
| Normal-vs-Stage2 |
9.842300E-03 |
| Normal-vs-Stage3 |
4.255899999972E-06 |
| Normal-vs-Stage4 |
1.83717999999722E-05 |
| Stage1-vs-Stage2 |
9.659200E-01 |
| Stage1-vs-Stage3 |
8.732100E-02 |
| Stage1-vs-Stage4 |
1.069440E-01 |
| Stage2-vs-Stage3 |
2.732800E-01 |
| Stage2-vs-Stage4 |
2.310600E-01 |
| Stage3-vs-Stage4 |
7.602600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.64710000000379E-05 |
| Normal-vs-AfricanAmerican |
1.182830E-01 |
| Normal-vs-Asian |
2.012200E-04 |
| Caucasian-vs-AfricanAmerican |
2.049200E-01 |
| Caucasian-vs-Asian |
6.064200E-01 |
| AfricanAmerican-vs-Asian |
1.405210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.01039999999853E-05 |
| Normal-vs-Female |
2.184700E-04 |
| Male-vs-Female |
2.351400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.384400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.28999999999369E-05 |
| Normal-vs-Age(61-80Yrs) |
6.0741999999947E-05 |
| Normal-vs-Age(81-100Yrs) |
5.039700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.324430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.170600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.753200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.731000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.615400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.703600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.788630E-01 |
| Classical-VS-Follicular |
4.151800E-01 |
| Classical-VS-Other |
1.222230E-01 |
| Classical-VS-Normal |
5.167500E-04 |
| Tall-VS-Follicular |
5.232200E-01 |
| Tall-VS-Other |
3.869200E-01 |
| Tall-VS-Normal |
3.369500E-04 |
| Follicular-VS-Other |
3.388200E-01 |
| Follicular-VS-Normal |
7.641800E-04 |
| Other-VS-Normal |
3.716000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.418280E-04 |
| Normal-vs-N1 |
3.51290000000226E-05 |
| N0-vs-N1 |
1.650000E-01 |
|
|
